Helena Adamis

Director Clinical Development at Fresenius Kabi - Bad Homburg, Hessen, DE

Helena Adamis's Colleagues at Fresenius Kabi
Patricia De-Lys

Director Alliance Management

Contact Patricia De-Lys

Valentine France-Lanord

Head of Alliance Management Biosimilars

Contact Valentine France-Lanord

Matthew Turner

Senior Director Government Affairs and Policy Biosimilars Europe, Asia, Latam & Canada

Contact Matthew Turner

Gabriele Tuller-Muenzberg

Director Marketing and Sales INS/MedTech, Member of the Management Team

Contact Gabriele Tuller-Muenzberg

Louise Ingram

Senior Director, Process Development and Manufacturing Sciences

Contact Louise Ingram

Andras Illes

Senior Director Clinical Affairs

Contact Andras Illes

View All Helena Adamis's Colleagues
Helena Adamis's Contact Details
HQ
(496) 172-6860
Location
Basel,Basel-Stadt,Switzerland
Company
Fresenius Kabi
Helena Adamis's Company Details
Fresenius Kabi logo, Fresenius Kabi contact details

Fresenius Kabi

Bad Homburg, Hessen, DE • 22278 Employees
Major Drugs

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. For more information, please visit www.fresenius-kabi.com. Imprint: https://www.fresenius-kabi.com/imprint

Global Healthcare Medical Technologies Biosimilars Clinical Nutrition Medical Devices Oncology Autoimmune Disease
Details about Fresenius Kabi
Frequently Asked Questions about Helena Adamis
Helena Adamis currently works for Fresenius Kabi.
Helena Adamis's role at Fresenius Kabi is Director Clinical Development.
Helena Adamis's email address is ***@fresenius-kabi.com. To view Helena Adamis's full email address, please signup to ConnectPlex.
Helena Adamis works in the Major Drugs industry.
Helena Adamis's phone number is (496) 172-6860
See more information about Helena Adamis